Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 60. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel air-oxidized synthesis for 3-hydroxyisoindolin-1-one derivatives. Reduces metal residue risks and offers scalable pharmaceutical intermediate manufacturing solutions.
Patent CN107460497A enables cost-effective electrochemical Minisci acylation. Eliminate silver catalysts for scalable pharmaceutical intermediate manufacturing.
Novel TEMPO-mediated hydroxylation patent CN107686460A offers cost-effective pharmaceutical intermediate manufacturing with scalable room temperature processes.
Novel sulfonamide route for 2-chloro-6-bromoaniline. High yield, mild conditions, cost-effective manufacturing for global supply chains and procurement.
Advanced chiral synthesis patent CN106699604B offers high purity Sacubitril Intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners.
Patent CN111825604A reveals a scalable Tucatinib synthesis route eliminating expensive Pd catalysts. Discover cost reduction strategies for pharmaceutical intermediates manufacturing.
Patent CN104447443B reveals a green Mannich route for Apremilast. Achieve high optical purity and significant cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN106083689A reveals a novel Silodosin synthesis route offering high purity and reduced impurities for reliable pharmaceutical intermediate supply chains.
Novel copper-catalyzed C-H activation method for 8-thiaxanthine compounds. High yield, scalable process for pharmaceutical intermediates like KW-6002.
Patent CN116003312B reveals a metal-free boron catalysis method for meta-selective pyridine functionalization, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106660957A details a scalable furfural route for high-purity fungicide intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN113200860B reveals high-purity SGLT2 inhibitor intermediate via flow chemistry. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Novel nickel-photocatalyzed method for (R)-1,3-diarylbutene offers mild conditions and high enantioselectivity, ensuring cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN116751196B introduces Rh660 catalyst for N-benzyltropine. Enhances yield and safety. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN115536605B details iridium-catalyzed oxazole synthesis enabling efficient COX-2 inhibitor production with reduced steps and enhanced supply chain reliability for global pharmaceutical manufacturers.
Discover the copper-catalyzed synthesis of [60]fullerene dihydropyridin-3-one derivatives. A cost-effective route for advanced electronic materials and photoelectric applications.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes production with enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106366069A reveals a cost-effective Cu-catalyzed synthesis for OLED intermediates. Discover supply chain advantages and high-yield manufacturing protocols.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.